The President's Council on Bioethics click here to skip navigation


The Changing Moral Focus of Newborn Screening: An Ethical Analysis by the President's Council on Bioethics

The President's Council on Bioethics
Washington, D.C.
December 2008


Acharya, Kruti, Paul D. Ackerman, and Lainie Friedman Ross. “Pediatricians’ Attitudes Toward Expanding Newborn Screening.” Pediatrics 116 (2005): e476-e484.

Alexander, Duane, and James W. Hanson. “NICHD Research Initiative in Newborn Screening.” Mental Retardation and Developmental Disabilities Research Reviews 12 (2006): 301-304.

________, and Peter C. van Dyck. “Neonatal Screening: Old Dogma or Sound Principle?” (letter to the editor) Pediatrics 119 (2007): 407.

________, and Peter C. van Dyck. “A Vision of the Future of Newborn Screening.” Pediatrics 117 Supplement (2006): S350-S354.

American Academy of Pediatrics. “Serving the Family from Birth to the Medical Home: A Report from the Newborn Screening Task Force.” Pediatrics 106 (2000): 383-427.

________. “AAP Endorses Newborn Screening Report from the American College of Medical Genetics.” Press release, May 12, 2005. (accessed November 6, 2008).

________, Committee on Bioethics. “Ethical Issues With Genetic Testing in Pediatrics.” Pediatrics 107 (2001): 1451-1455.

American College of Medical Genetics. Newborn Screening: Toward a Uniform Screening Panel and System. Edited by Michael S. Watson, Marie Y. Mann, Michele A. Lloyd-Puryear, Piero Rinaldo, and R. Rodney Howell. Washington, D.C.: Health Resources and Services Administration, 2005. (accessed December 13, 2008). Also published in Genetics in Medicine 8 (2006): 1s-250s. (accessed December 13, 2008).

American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group. “Tandem Mass Spectrometry in Newborn Screening.” Genetics in Medicine 2 (2000): 267-269.

American College of Obstetricians and Gynecologists and the American College of Medical Genetics. “Cystic Fibrosis Carrier Testing: The Decision is Yours.” Washington, D.C.: ACOG, 2001. (accessed November 6, 2008).

American Society of Human Genetics and the American College of Medical Genetics. “Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.” American Journal of Human Genetics 57 (1995): 1233-1241.

Annas, George J. “Mandatory PKU Screening: The Other Side of the Looking Glass.” American Journal of Public Health 72 (1982): 1401-1403.

Atkinson, Kathleen, Barry Zuckerman, Joshua M. Sharfstein, Donna Levin, Robin J. R. Blatt, and Howard K. Koh. “A Public Health Response to Emerging Technology: Expansion of the Massachusetts Newborn Screening Program.” Public Health Reports 116 (2001): 122-131.

Autti-Rämö, Ilona, Marjukka Mäkelä, Harri Sintonen, Hanna Koskinen, Liisa Laajalahti, Ritva Halila, Helena Käriäinen, Risto Lapatto, Kirsti Näntö-Salonen, Kari Pulkxi, Martin Renlund, Matti Salo, and Tiina Tyni. “Expanding Screening for Rare Metabolic Disease in the Newborn: An Analysis of Costs, Effect and Ethical Consequences for Decision-Making in Finland.” Acta Paediatrica 94 (2005): 1126-1136.

Bailey, Jr., Donald B., Laura M. Beskow, Arlene M. Davis, and Debra Skinner. “Changing Perspectives on the Benefits of Newborn Screening.” Mental Retardation and Developmental Disabilities Research Reviews 12 (2006): 270-279.

Baily, Mary Ann, and Thomas H. Murray. “Ethics, Evidence, and Cost in Newborn Screening.” Hastings Center Report 38 (2008): 23-31.

Banta-Wright, Sandra, and Robert Steiner. “Tandem Mass Spectrometry in Newborn Screening, A Primer of Neonatal and Perinatal Nurses.” Journal of Perinatal and Neonatal Nursing 1 (2004): 41-58.

Beecher, Henry K. “Ethics and Clinical Research.” New England Journal of Medicine 274 (1966): 1354-1360.

Bernard, Claude. Introduction to the Study of Experimental Medicine. Translated by Henry C. Greene. New York: Dover, 1957 (1865).

Bodamer, Olaf A., Georg F. Hoffmann, and Martin Lindner. “Expanded Newborn Screening in Europe 2007.” Journal of Inherited Metabolic Disease 30 (2007): 439-444.

Bodegård, Göran, Karin Fyrö, and Agne Larsson. “Psychological Reactions in 102 Families With a Newborn Who Has a Falsely Positive Screening Test for Congenital Hypothyroidism.” Acta Paediatrica Scandinavica Supplement 304 (1983): 2-21.
Borrajo, Gustavo Juan Carlos. “Newborn Screening in Latin America at the Beginning of the 21st Century.” Journal of Inherited Metabolic Disease 30 (2007): 466-481.

Botkin, Jeffrey R., Ellen Wright Clayton, Norman C. Fost, Wylie Burke, Thomas H. Murray, Mary Ann Baily, Benjamin Wilfond, Alfred Berg, and Lainie Friedman Ross. “Newborn Screening Technology: Proceed With Caution.” Pediatrics 117 (2006): 1793-1799.

Bradbury, Angela R., Linda Patrick-Miller, Kimberly Pawlowski, Comfort N. Ibe, Shelley A. Cummings, Olufunmilayo I. Olopade, and Christopher K. Daugherty. “Should Genetic Testing for BRCA1/2 Be Permitted for Minors? Opinions of BRCA Mutation Carriers and Their Adult Offspring.” American Journal of Medical Genetics Part C: Seminars in Medical Genetics 148C (2008): 70-77.

Braddock, Clarence H., III, Kelly A. Edwards, Nicole M. Hasenberg, Tracy L. Laidley, and Wendy Levinson. “Informed Decision Making in Outpatient Practice: Time to Get Back to Basics.” Journal of the American Medical Association 282 (1999): 2313-2320.

Burke, Wylie, and Bruce M. Psaty. “Personalized Medicine in the Genomic Era.” Journal of the American Medical Association 298 (2007): 1682-1684.

Callahan, Daniel. What Price Better Health? Hazards of the Research Imperative. Berkeley, California: University of California Press, 2003.

Campbell, Elizabeth, and Lainie Friedman Ross. “Parental Attitudes Regarding Newborn Screening of PKU and DMD.” American Journal of Medical Genetics 120A (2003): 209-214.

Centers for Disease Control and Prevention, “Impact of Expanded Newborn Screening—United States, 2006,” Journal of the American Medical Association 300 (2008): 2242-2244.

________, Division of Laboratory Sciences. “Quality Assurance and Proficiency Testing for Newborn Screening.” (accessed November 6, 2008).

________, Environmental Health Laboratory. “National Report on Human Exposure to Environmental Chemicals.” (accessed November 7, 2008).

________, Single Gene Disorders and Disability (SGDD). “Screening and Diagnosis.”
            ncbddd/duchenne/screening.htm (accessed November 6, 2008).

Chace, Donald. “A Layperson’s Guide to Tandem Mass Spectrometry and Newborn Screening.” (accessed November 9, 2008).

Christensen, Kaare, and Jeffrey C. Murray. “What Genome-Wide Association Studies Can Do for Medicine.” New England Journal of Medicine 356 (2007): 1094-1097.

Clayton, Ellen W. “Talking With Parents Before Newborn Screening.” Journal of Pediatrics 147 (2005): S26-S29.

________. “Incidental Findings in Genetics Research Using Archived DNA.” The Journal of Law, Medicine & Ethics 36 (2008): 286-291.

Collins, Francis S., and Victor A. McKusick. “Implications of the Human Genome Project for Medical Science.” Journal of the American Medical Association 285 (2001): 540-544.
Crombez, Eric A., and Stephen D. Cederbaum. “Hyperargininemia Due to Liver Arginase Deficiency.” Molecular Genetics and Metabolism 84 (2005): 243-251.

Croyle, Robert T. Psychosocial Effects of Screening for Disease Prevention and Detection. New York: Oxford, 1995.

Cystic Fibrosis Foundation. “Newborn Screening.” (accessed November 6, 2008).

Davis, Dena S. “Genetic Dilemmas and the Child’s Right to an Open Future.” Hastings Center Report 27 (1997): 7-15.

Davis, Terry C., Sharon G. Humiston, Connie L. Arnold, Joseph A. Bocchini, Pat F. Bass, III, Estela M. Kennen, Anna Bocchini, Donna Williams, Penny Kyler, and Michele Lloyd-Puryear. “Recommendations for Effective Newborn Screening Communication: Results of Focus Groups With Parents, Providers, and Experts.” Pediatrics 117 (2006): S326-S334.

Desposito, Franklin, Michele A. Lloyd-Puryear, Thomas F. Tonniges, Francisco Rhein, and Marie Mann. “Survey of Pediatrician Practices in Retrieving Statewide Authorized Newborn Screening Results.” Pediatrics 108 (2001): E22.

Deyo, Richard A. “Cascade Effects of Medical Technology.” Annual Review of Public Health 23 (2002): 23-44.

Dixon, Darrin P. “Informed Consent or Institutionalized Eugenics? How the Medical Profession Encourages Abortion of Fetuses with Down Syndrome.” Issues in Law & Medicine 24 (2008): 3-59.

Duncan, Rony E., Lynn Gillam, Julian Savulescu, Robert Williamson, John G. Rogers, and Martin B. Delatycki. “‘You’re One of Us Now’: Young People Describe Their Experiences of Predictive Genetic Testing for Huntington Disease (HD) and Familial Adenomatous Polyposis (FAP).” American Journal of Medical Genetics Part C: Seminars in Medical Genetics 148 (2008): 47-55.

Faden, Ruth, A. Judith Chwalow, Neil A. Holtzman, and Susan D. Horn. “A Survey to Evaluate Parental Consent as Public Policy for Neonatal Screening.” American Journal of Public Health 72 (1982): 1347-1352.

________, Neil A. Holtzman, and A. Judith Chwalow. “Parental Rights, Child Welfare, and Public Health: The Case of PKU Screening.” American Journal of Public Health 72 (1982): 1396-1400.

Fant, Kathryn E., Sarah J. Clark, and Alex R. Kemper. “Completeness and Complexity of Information Available to Parents from Newborn-Screening Programs.” Pediatrics 115 (2005): 1268-1272.

Fost, Norman. “Ethical Implications of Screening Asymptomatic Individuals.” FASEB (Federation of American Societies for Experimental Biology) Journal 6 (1992): 2813-2817.

Frankenburg, William K. “Selection of Diseases and Tests in Pediatric Screening.” Pediatrics 54 (1974): 612-616.

Fuller, Barbara P., Mary Jo Ellis Kahn, P.A. Barr, Leslie Biesecker, Ellen Crowley, Judy Garber, Monique K. Mansoura, Patricia Murphy, Jeffrey Murray, J. Phillips, Karen Rothenberg, Mark Rothstein, Jill Stopfer, Gary Swergold, Barbara Weber, Francis S. Collins, and Kathy L. Hudson. “Privacy in Genetics Research.” Science 285 (1999): 1359-1361.

Gelb, Michael H., Frantisek Turecek, C. Ron Scott, and Nestor A. Chamoles. “Direct Multiplex Assay of Enzymes in Dried Blood Spots by Tandem Mass Spectrometry for the Newborn Screening of Lysosomal Storage Disorders.” Journal of Inheritable Metabolic Disease 29 (2006): 397-404.

Gollust, Sarah E., Benjamin S. Wilfond, and Sara C. Hull. “Direct-to-Consumer Sales of Genetic Services on the Internet.” Genetics in Medicine 5 (2006): 332-337.

Greely, Henry T. “The Uneasy Ethical and Legal Underpinnings of Large-Scale Genomic Biobanks.” Annual Review of Genomics and Human Genetics 8 (2007): 343-364.

________. “Iceland’s Plan for Genomics Research: Facts and Implications.” Jurimetrics 40 (2000): 153-191.

Green, Josephine M., Jenny Hewison, Hilary L. Bekker, Louise D. Bryant, and Howard S. Cuckle. “Psychosocial Aspects of Genetic Screening of Pregnant Women and Newborns: A Systematic Review.” Health Technology Assessment 8 (2004): 1-109.

Green, Michael J., and Jeffrey R. Botkin. “‘Genetic Exceptionalism’ in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests.” Annals of Internal Medicine 138 (2003): 571-575.

Green, Morris. “Vulnerable Child Syndrome and Its Variants.” Pediatrics in Review 8 (1986): 75-80.

________, and Albert J. Solnit. “Reactions to the Threatened Loss of a Child: A Vulnerable Child Syndrome.” Pediatrics 34 (1964): 58-66.

Green, Nancy S., and Kenneth A. Pass. “Neonatal Screening by DNA Microarray: Spots and Chips.” Nature Reviews Genetics 6 (2005): 147-151.

Gurian, Elizabeth A., Daniel D. Kinnamon, Judith J. Henry, and Susan E. Waisbren. “Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result.” Pediatrics 6 (2006): 1915-1921.

Guthrie, Robert. “The Origin of Newborn Screening.” Screening 1 (1992): 5-15.

Guttmacher, Alan E., and Francis S. Collins. “Welcome to the Genomic Era.” New England Journal of Medicine 349 (2003): 996-998.

________, Mary E. Porteous, and Joseph D. McInerny. “Educating Health-Care Professionals about Genetics and Genomics.” Nature Reviews Genetics 8 (2007): 151-157.

Hayden, Erica C. “$5,000 Genome Next Year, Company Promises.” Nature News (October 6, 2008), (accessed November 6, 2008).

Health Council of the Netherlands. Neonatal Screening. The Hague, The Netherlands: Health Council of the Netherlands, 2005. (accessed November 18, 2008).

Hiller, Elaine H., Gretchen Landenburger, and Marvin R. Natowicz. “Public Participation in Medical Policy Making and the Status of Consumer Autonomy: The Example of Newborn Screening Programs in the United States.” American Journal of Public Health 87 (1997): 1280-1288.

Holtzman, Neil A., and Theresa M. Marteau. “Will Genetics Revolutionize Medicine?” New England Journal of Medicine 343 (2000): 141-144.

________, and Michael S. Watson. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Maryland: National Institutes of Health, 1997. (accessed November 6, 2008).

Howell, R. Rodney. “We Need Expanded Newborn Screening.” Pediatrics 117 (2006): 1800-1805.

Howse, Jennifer L., Marina Weiss, and Nancy S. Green. “Critical Role of the March of Dimes in the Expansion of Newborn Screening.” Mental Retardation and Developmental Disabilities Research Reviews 12 (2006): 280-287.

Institute of Medicine of the National Academies, Committee on Assessing Genetic Risks. Assessing Genetic Risks: Implications for Health and Social Policy. Edited by Lori B. Andrews, Jane E. Fullarton, Neil A. Holtzman, and Arno G. Motulsky. Washington, D.C.: National Academies Press, 1994.

Johnson, Kay, Michele A. Lloyd-Puryear, Marie Y. Mann, Lauren Raskin Ramos, and Bradford L. Therrell. “Financing State Newborn Screening Programs: Sources and Uses of Funds.” Pediatrics 117 (2006): S270-S279.

Kaiser, Jocelyn. “U.S. Hospital Launches Large Biobank of Children’s DNA.” Science 312 (2006): 1584-1585.

Kashork, Catherine D., Aaron Theisen, and Lisa G. Shaffer. “Prenatal Diagnosis Using Array CGH.” Methods in Molecular Biology 444 (2008): 59-70.

Kaufman, David, Gail Geller, Lisa Leroy, Juli Murphy, Joan Scott, and Kathy Hudson. “Ethical Implications of Including Children in a Large Biobank for Genetic-Epidemiologic Research: A Qualitative Study of Public Opinion.” American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 148C (2008): 31-39.


Kaye, Celia I., Judith Livingston, Mark Canfield, Marie Mann, Michele Lloyd-Puryear, and Bradford L. Therrell, Jr. “Assuring Clinical Genetic Services for Newborns Identified Through U.S. Newborn Screening Programs.” Genetics in Medicine 9 (2007): 518-527.
Kramer, Ralph L., Robert K. Jarve, Yuval Yaron, Mark P. Johnson, Jenifer Lampinen, Stefanie B. Kasperski, and Mark I. Evans. “Determinants of Parental Decisions After the Prenatal Diagnosis of Down Syndrome.” American Journal of Medical Genetics Part A 79 (1998): 172-174.

Kuehn, Bridget M. “Prenatal Genome Testing Sparks Debate.” Journal of the American Medical Association 300 (2008): 1637-1639.

la Marca, Giancarlo, Sabrina Malvagia, Bruno Casetta, Elisabetta Pasquini, Maria A. Donati, and Enrico Zammarchi. “Progress in Expanded Newborn Screening for Metabolic Conditions by LC-MS/MS in Tuscany: Update on Methods to Reduce False Tests.” Journal of Inherited Metabolic Disease Short Report #127 online (2008). (accessed November 18, 2008).

Li, Yijun, C. Ronald Scott, Nestor A. Chamoles, Ahmad Ghavami, B. Mario Pinto, Frantisek Turecek, and Michael H. Gelb. “Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening.” Clinical Chemistry 50 (2004): 1785-1796.

Lindner, Martin, Ghassan Abdoh, Junmin Fang-Hoffmann, Noora Shabeck, M. Al Sayrafi, Mohammed Al Janahi, Sirikit Ho, Mohammed O. Abdelrahman, Tawfeg Ben-Omran, Abdulbari Bener, Andreas Schulze, Hilal Al Rifai, Ghalia Al Thani, Georg F. Hoffmann. “Implementation of Extended Neonatal Screening and a Metabolic Unit in the State of Qatar: Developing and Optimizing Strategies in Cooperation with the Neonatal Screening Center in Heidelberg.” Journal of Inherited Metabolic Disease 30 (2007): 522-529.

Lisker, Rubén, and Alessandra Carnevale. “Changing Opinions of Mexican Geneticists on Ethical Issues.” Archives of Medical Research 37 (2006): 794-803.

Loeber, J. Gerard. “Neonatal Screening in Europe; The Situation in 2004.” Journal of Inherited Metabolic Disease 30 (2007): 430-438.

Ludmerer, Kenneth M. Time to Heal: American Medical Education from the Turn of the Century to the Era of Managed Care. New York: Oxford University Press, 1999.

Mandl, Kenneth D., Shlomit Feit, Cecilia Larson, and Isaac S. Kohane. “Newborn Screening Program Practices in the United States: Notification, Research, and Consent.” Pediatrics 109 (2002): 269-273.

March of Dimes. “March of Dimes Statement on Newborn Screening Report.” (September 22, 2004.) (accessed November 6, 2008).

Marteau, Theresa M., and John Weinman. “Self-Regulation and the Behavioural Response to DNA Risk Information: A Theoretical Analysis and Framework for Future Research.” Social Science and Medicine 62 (2006): 1360-1368.

Massachusetts Department of Public Health. “105 CMR270.000: Blood Screening of Newborns for Treatable Diseases and Disorders.” Draft Regulations of July 18, 2008. (accessed November 9, 2008).

________. “Re: Informational Briefing on Proposed Amendments to 105 CMR 270.000: Regulations Governing Testing of Newborns for Treatable Disease.” Memorandum of August 13, 2008. (accessed November 9, 2008).

McCarthy, Mark I., Goncalo R. Abecasis, Lon R. Cardon, David B. Goldstein, Julian Little, John P.A. Ioannidis, and Joel N. Hirschhorn. “Genome-Wide Association Studies for Complex Traits: Consensus, Uncertainty and Challenges.” Nature Reviews Genetics 9 (2008): 356-369.

Millington, David. “Newborn Screening for Lysosomal Storage Disorders.” Clinical Chemistry 51 (2008): 808-809.

Mold, James W., and Howard F. Stein. “The Cascade Effect in the Clinical Care of Patients.” New England Journal of Medicine 314 (1986): 512-514.

Moyer, Virginia A., Ned Calonge, Steben M. Teutsch, and Jeffrey R. Botkin, on behalf of the United States Preventive Services Task Force. “Expanding Newborn Screening: Process, Policy, and Priorities.” Hastings Center Report 38 (2008): 32-39.

National Bioethics Advisory Commission. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Volume 1. Rockville, MD: NBAC, 1999. (accessed November 6, 2008).

National Human Genome Research Institute. “The History of Newborn Phenylketonuria Screening in the U.S.” By Diane B. Paul in Appendix 5 of Neil A. Holtzman and Michael S. Watson, Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Bethesda, MD: National Institutes of Health, 1997. (accessed November 6, 2008).


________. National Institutes of Health-Department of Energy Joint Working Group on the Ethical, Legal, and Social Implications of Human Genome Research, Task Force on Genetic Testing. Promoting Safe and Effective Genetic Testing in the United States. Washington, D.C.: National Institutes of Health, 1997.

National Newborn Screening and Genetics Resource Center. “National Newborn Screening Status Report.” October 2008. (accessed November 6, 2008).

National Newborn Screening Information System (NNIS) Database. (accessed November 9, 2008).

National Research Council Committee for the Study of Inborn Errors of Metabolism. Genetic Screening Programs, Principles, and Research. Washington, D.C.: National Academy of Sciences, 1975.

Natowicz, Marvin R. “Newborn Screening—Setting Evidence-Based Policy for Protection.” New England Journal of Medicine 353 (2005): 867-870.

Nebraska Supreme Court. In re Interest of Anaya, A Child Under 18 Years of Age. No. S-07-1136, filed December 5, 2008. 276 Neb. 825. (accessed December 9, 2008).

Neidich, Alon B., Josh W. Joseph, Carole Ober, and Lainie Friedman Ross. “Empirical Data about Women’s Attitudes Towards a Hypothetical Pediatric Biobank.” American Journal of Medical Genetics Part A 146A (2008): 297-304.


The New England Newborn Screening Program, University of Massachusetts Medical School, State Laboratory Institute. “Answers to Common Questions About Newborn Screening.” (accessed November 6, 2008).

Newson, Ainsley J. “Ethical Aspects Arising from Non-Invasive Fetal Diagnosis.” Seminars in Fetal and Neonatal Medicine 13 (2008): 103-108.

Nørgaard-Pedersen, Bent, and David M. Hougaard. “Storage Policies and Use of the Danish Newborn Screening Biobank.” Journal of Inherited Metabolic Disease 30 (2007): 530-536.

Olney, Richard S. “Preventing Morbidity and Mortality from Sickle Cell Disease: A Public Health Perspective.” American Journal of Preventive Medicine 16 (1999): 116-121.

________, Cynthia A. Moore, Jelili A. Ojodu, Mary Lou Lindegren, and W. Harry Hannon. “Storage and Use of Residual Dried Blood Spots from State Newborn Screening Programs.” Journal of Pediatrics 148 (2006): 618-622.

Pacey, Arnold. The Culture of Technology. Cambridge, Massachusetts: MIT Press, 1985.

Padilla, Carmencita D., and Bradford L. Therrell. “Newborn Screening in the Asia Pacific Region.” Journal of Inherited Metabolic Disease 30 (2007): 490-506.

Pandor, Abdullah, Joe Eastham, Catherine Beverley, James Chilcott, and Suzy Paisley. “Clinical Effectiveness and Cost-Effectiveness of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry: A Systematic Review.” Health Technology Assessment 8 (2004): 1-121.


Parsons, Evelyn P., Angus J. Clark, Kerry Hood, Emma Lycett, Don M. Bradley. “Newborn Screening for Duchenne Muscular Dystrophy: A Psychosocial Study.” Archives of Disease in Childhood Fetal and Neonatal Edition 86 (2002): F91-F95.

Pass, Kenneth A., Nancy S. Green, Fred Lorey, John Sherwin, and Anne Marie Comeau. “Pilot Programs in Newborn Screening.” Mental Retardation and Developmental Disabilities Research Reviews 12 (2006): 293-300.

________, Peter A. Lane, Paul M. Fernhoff, Cynthia F. Hinton, Susan R. Panny, John S. Parks, Mary Z. Pelias, William J. Rhead, Sonya I. Ross, Doris L. Wethers, and Louis J. Elsas. “US Newborn Screening System Guidelines II: Follow-Up of Children, Diagnosis, Management, and Evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN).” Journal of Pediatrics 137 (2000): S1-S46.

Paul, Diane B. “Patient Advocacy in Newborn Screening: Continuities and Discontinuities.” American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 148C (2008): 8-14.

Pellegrino, Edmund D., and David C. Thomasma. For the Patient’s Good: The Restoration of Beneficence in Health Care. New York: Oxford, 1988.

Pollitt, Rodney J. “International Perspectives on Newborn Screening.” Journal of Inherited Metabolic Disease 29 (2006): 390-396.

________. “Introducing New Screens: Why Are We All Doing Different Things?” Journal of Inherited Metabolic Disease 30 (2007): 423-429.

Pullman, Daryl, and Kathy Hodgkinson. “Genetic Knowledge and Moral Responsibility: Ambiguity at the Interface of Genetic Research and Clinical Practice.” Clinical Genetics 69 (2006): 199-203.

Reich, David E., and Eric S. Lander. “On the Allelic Spectrum of Human Disease.” Trends in Genetics 17 (2001): 502-510.

Rinaldo, Piero, Saba Zafari, Silvia Tortorelli, and Dietrich Matern. “Making the Case for Objective Performance Metrics in Newborn Screening by Tandem Mass Spectrometry.” Mental Retardation and Developmental Disabilities Research Reviews 12 (2006): 255–261.

Risch, Neil, and Kathleen R. Merikangas. “The Future of Genetic Studies of Complex Human Diseases.” Science 273 (1996): 1516–1517.

Robertson, John A. “The $1000 Genome: Ethical and Legal Issues in Whole Genome Sequencing of Individuals.” American Journal of Bioethics 3 (2003): W35-W43.

Roden, Dan M., Jill M. Pulley, Melissa A. Basford, Gordon R. Bernard, Ellen W. Clayton, Jeffrey R. Balser, and Dan R. Masys. “Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine.” Clinical Pharmacology and Therapeutics 84 (2008): 362-369.

Ross, Lainie Friedman. “Screening for Conditions that Do Not Meet the Wilson and Jungner Criteria: The Case of Duchenne Muscular Dystrophy.” American Journal of Medical Genetics Part A 140A (2006): 914-922.

Rothenberg, Michael B., and Edward M. Sills. “Iatrogenesis: The PKU Anxiety Syndrome.” Journal of the American Academy of Child Psychiatry 7 (1968): 689-692.

Saadallah, Amal A., and Mohamed S. Rashed, “Newborn Screening: Experiences in the Middle East and North Africa,” Journal of Inherited Metabolic Disease 30 (2007): 482-489.


Satoo, Trilochan, Sau Cheung, Patricia Ward, Sandra Darilek, Ankita Patel, Daniela Del Gaudio, Sung Hae Kang, Seema Lalani, Jiangzhen Li, Sallie Mcadoo, Audrew Burke, Chad Shaw, Pawel Stankiewicz, A. Craig Chinault, Ignatia Van Den Veyver, Benjamin Roa, Arthur Beaudet, and Christine Eng. “Prenatal Diagnosis of Chromosomal Abnormalities Using Array-Based Comparative Genomic Hybridization.” Genetics in Medicine 8 (2006): 719-727.

Schneider, Carl E. “Some Realism About Informed Consent.” Journal of Laboratory and Clinical Medicine 145 (2005): 289-291.

Schulze, Andreas, Martin Lindner, Dirk Kohlmuller, Katherina Olgemoller, Ertan Mayatepek, and George F. Hoffmann. “Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization-Tandem Mass Spectrometry: Results, Outcome, and Implications.” Pediatrics 111 (2003): 1399-1406.

Service, Robert F. “Gene Sequencing. The Race for the $1000 Genome.” Science 311 (2006): 1544-1546.

Shaffer, Lisa G., Justine Coppinger, Sarah Alliman, Beth A. Torcha, Aaron Theison, Blake C. Ballif, Bassem A. Bejjani. “Comparison of Microarray-Based Detection Rates for Cytogenetic Abnormalities in Prenatal and Neonatal Specimens.” Prenatal Diagnosis 28 (2008): 789-795.

Signature Genomic Laboratories. “Signature Prenatal Chip.” (accessed November 6, 2008).

Singer, Emily. “Five Thousand Bucks for Your Genome: A New Sequencing Service Could Change the Face of Human Genomics.” Technology Review (October 6, 2008). (accessed November 6, 2008).

________. “The $2 Million Genome.” Technology Review (June 1, 2007). (accessed November 6, 2008).

Skinner, Debra, Karen L. Sparkman, and Donald B. Bailey, Jr. “Screening for Fragile X Syndrome: Parent Attitudes and Perspectives.” Genetics in Medicine 5 (2003): 378-384.

Snyderman, Ralph, and R. Sanders Williams. “Prospective Medicine: The Next Health Care Transformation.” Academic Medicine 78 (2003): 1079-1084.

Sox, Colin M., William O. Cooper, Thomas D. Koepsell, David L. DiGuiseppe, and Dimitri A. Christakis. “Provision of Pneumococcal Prophylaxis for Publicly Insured Children with Sickle Cell Disease.” Journal of the American Medical Association 290 (2003): 1057-1061.

Stein, Rob. “Fresh Hopes and Concerns As Fetal DNA Tests Advance.” The Washington Post, October 26, 2008. (accessed November 6, 2008).

Tarini, Beth A., Dimitri A. Christakis, and H. Gibert Welch. “State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results.” Pediatrics 118 (2006): 448-456.

Therrell, Bradford L., and John Adams. “Newborn Screening in North America.” Journal of Inherited Metabolic Disease 30 (2007): 447-465.

________, Alissa Johnson, and Donna Williams. “Status of Newborn Screening Programs in the United States.” Pediatrics 117 (2006): S212-S252.

________, Susan R. Panny, and A. Davidson. “U.S. Newborn Screening System Guidelines: Statement of the Council of Regional Networks for Genetic Services (CORN).” Screening 1 (1992): 135-147.

Thomasgard, Michael, and W. Peter Metz. “Parental Overprotection and Its Relation to Perceived Child Vulnerability.” American Journal of Orthopsychiatry 67 (1997): 330-335.

Thomasma, David C., and Judith Lee Kissell, ed. The Health Care Professional As Friend and Healer: Building on the Work of Edmund D. Pellegrino. Washington, D.C.: Georgetown University Press, 2000.

Tluczek, Audrey, Elaine H. Mischler, Barbara Bowers, Nanette M. Peterson, Mary E. Morris, Phili M. Farrell, W. Theodore Bruns, Holly Colby, Catherine McCarthy, Norman Fost, and Patrick Carey. “Psychological Impact of False-Positive Results When Screening for Cystic Fibrosis.” Pediatric Pulmonology Supplement 7 (1991): 29-37.

Tocqueville, Alexis de. Democracy in America. Translated by Harvey C. Mansfield and Delba Winthrop. Chicago, Illinois: University of Chicago Press, 2000 [1836, 1840].

UK Human Genetics Commission. Profiling the Newborn: A Prospective Gene Technology? A report from a Joint Working Group of the Human Genetics Commission and the UK National Screening Committee. London: HGC, March 2005. (accessed November 6, 2008).

UK National Screening Committee. “The UK National Screening Committee’s Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme.” March 24, 2003. (accessed November 18, 2008).
U.S. Code. Title 42. Health and Public Welfare. Sections 300b-1, 6, 8-10.

U.S. Congress. “Clinical Laboratory and Improvement Amendments of 1988 (CLIA-88).” 100th Congress, 1988. (accessed November 6, 2008).

U.S. Congress. “Genomics and Personalized Medicine Act of 2007 (S.976).” 110th Congress, 1st session, March 26, 2007. (accessed November 6, 2008).

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. “Class II Special Controls Guidance Document: Newborn Screening Test Systems for Amino Acids, Free Carnitine, and Acylcarnitines Using Tandem Mass Spectrometry.” November 24, 2004. (accessed November 18, 2008).

________, Health Resources and Services Administration, Advisory Committee on Heritable Disorders in Newborns and Children. Letters to the Secretary, U.S. Department of Health and Human Services. June 13, 2005. (accessed November 9, 2008).

________, Office for Human Research Protections (OHRP). Institutional Review Board (IRB) Guidebook. Washington, D.C.: National Institutes of Health, 1993. (accessed November 9, 2008).

________, Secretary’s Advisory Committee on Genetics, Health, and Society. Policy Issues Associated with Undertaking a New Large U.S. Population Cohort Study of Genes, Environment, and Disease. Bethesda, MD: U.S. Department of Health and Human Services, 2007. (accessed November 6, 2008).

U.S. Executive Office of the President, Office of Management and Budget. Statement of Administration Policy H.R. 493—Genetic Information Nondiscrimination Act of 2007. (April 25, 2007) (accessed November 6, 2008).

U.S. Public Health Service, Division of Research Grants. “Clinical Investigations Using Human Subjects.” Policy and Procedure Order #129. February 8, 1966.

University of Michigan, C.S. Mott Children’s Hospital National Poll on Children’s Health. Genetic Testing and DNA Biobanks—For Whom, and When? 2007. (accessed November 6, 2008).

University of Washington, Institute for Public Health Genetics. “Informed Consent and Newborn Screening” by Dena Freeman. MPH Practicum (2008). (accessed November 9, 2008).

Vallance, Hilary, Sandra Sirrs, Fiona Bamforth, and Sylvia Stockler-Ipsiroglu. “In Response to ‘Newborn Screening in North America’ (Therrell and Adams [2007] J. Inherit. Met. Dis. 30: 447-465).” Journal of Inherited Metabolic Disease (2008) (Letter to the Editor, published October 16, 2008).

van Calcar, Sandra C., Linda A. Gleason, Heidi Lindh, Gary Hoffman, William Rhead, Gerard Vockley, Jon A. Wolff, and Maureen S. Durkin. “2-Methylbutyryl-CoA Dehydrogenase Deficiency in Hmong Infants Identified by Expanded Newborn Screen.” Wisconsin Medical Journal 106 (2007): 12-15.
 Wade, Nicholas. “A Dissenting Voice as the Genome Is Sifted to Fight Disease.” The New York Times (September 15, 2008), (accessed November 6, 2008).

Wald, Nicholas. “Neonatal Screening: Old Dogma or Sound Principle?” (Letter to the Editor) Pediatrics 119 (2007): 406-407.

Ware, James H. “The Limitations of Risk Factors as Prognostic Tools.” New England Journal of Medicine 355 (2006): 2615-2617.

Wertz, Dorothy C. “Ethical Issues in Pediatric Genetics: Views of Geneticists, Parents and Primary Care Physicians.” Health Law Journal 6 (1998): 3-42.

________, and John C. Fletcher. Genetics and Ethics in Global Perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2004.

________, John C. Fletcher, and Kåre Berg (consultants to the World Health Organization). Review of Ethical Issues in Medical Genetics. Geneva: WHO, 2003. (accessed November 6, 2008).

Wexler, Nancy S. “Clairvoyance and Caution: Repercussions from the Human Genome Project.” in The Code of Codes: Scientific and Social Issues in the Human Genome Project. Edited by Daniel J. Kevles and Leroy Hood. Cambridge, Massachusetts: Harvard University Press, 1992.

________. “Genetic Information: Its Significance for Patients, Health Professionals, Ethics, and Policy Development” (paper presented at the The President’s Council on Bioethics Twenty-fifth Meeting, Washington, D.C., September 8, 2006). (accessed November 6, 2008).
________. “The Tiresias Complex: Huntington’s Disease as a Paradigm of Testing for Late-Onset Disorders.” FASEB (Federation of American Societies for Experimental Biology) Journal 6 (1992): 2820-2825.

Wilfond, Benjamin S., and Lainie Friedman Ross. “From Genetics to Genomics: Ethics, Policy, and Parental Decision-Making.” Journal of Pediatric Psychology (publication ahead of print) July 22, 2008: 1-9.

Willis, Evan. “The ‘New’ Genetics and the Sociology of Medical Technology.” Journal of Sociology 34 (1998): 170-183.

Wilson, James M. G., and Gunnar Jungner. Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968. (accessed November 6, 2008).

World Health Organization, European Observatory on Health Systems and Policies. “Policy Brief: Screening in Europe” by Walter W. Holland, Susie Stewart, and Cristina Masseria. Geneva: World Health Organization, 2006. (accessed November 18, 2008).


  - The President's Council on Bioethics -  
Home Site Map Disclaimers Privacy Notice Accessibility NBAC HHS